Fragile site induction by aphidicolin may be increased in parents of neuroblastoma patients.
We recently demonstrated an increased expression of fragile sites, induced by aphidicolin, in lymphocytes of neuroblastoma patients. We have now extended our studies to parents of affected children with neuroblastoma to verify if this characteristic may be genetically transmitted. We have examined 20 families. In most of them, the hypersensitivity to aphidicolin was found in the affected child and in at least one parent. Moreover, some of the parents showed an increase in the expression of the fragile sites 1p32, 1p13, or both that are preferentially expressed in neuroblastoma patients. The possible relations between the hypersensitivity to aphidicolin and the inheritance of predisposition to neuroblastoma must be clarified.
Vernole
P
P
Department of Public Health and Cell Biology, 2nd University of Rome, Italy.
Tedeschi
B
B
Nicoletti
B
B
D000293:Adolescent; D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology*; D016590:Aphidicolin; D002478:Cells, Cultured; D002648:Child; D043283:Chromosome Fragile Sites; D002873:Chromosome Fragility; D002878:Chromosomes, Human, Pair 1; D004224:Diterpenes / Q000494:pharmacology*; D004342:Drug Hypersensitivity; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008214:Lymphocytes / Q000187:drug effects; D008297:Male; D009447:Neuroblastoma / Q000235:genetics*
D000903:Antibiotics, Antineoplastic; D004224:Diterpenes; D016590:Aphidicolin